MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/90/0.1/20.06.25 Share Price

Warrant

DE000ME3GY86

Market Closed - Börse Stuttgart 17:51:49 14/06/2024 BST
0.43 EUR +2.38% Intraday chart for MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/90/0.1/20.06.25
1 month+34.38%
3 months+137.57%
Date Price Change
14/06/24 0.43 +2.38%
13/06/24 0.42 -4.55%
12/06/24 0.44 +10.00%
11/06/24 0.4 -6.98%
10/06/24 0.43 0.00%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 05:51 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
Issuer Morgan Stanley
WKN ME3GY8
ISINDE000ME3GY86
Date issued 13/11/2023
Strike 90 $
Maturity 20/06/2025 (370 Days)
Parity 10 : 1
Emission price 0.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.44
Lowest since issue 0.056
Spread 0.01
Spread %2.27%

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
158.6 USD
Average target price
174.4 USD
Spread / Average Target
+9.95%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW